tradingkey.logo

BRIEF-Kura Oncology And Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial

ReutersFeb 5, 2025 9:02 PM

- Kyowa Kirin Co Ltd 4151.T:

  • KURA ONCOLOGY AND KYOWA KIRIN ANNOUNCE POSITIVE ZIFTOMENIB MONOTHERAPY REGISTRATIONAL TRIAL AND POSITIVE FDA FEEDBACK FOR UPCOMING FRONTLINE COMBINATION TRIAL DESIGNS

  • KURA ONCOLOGY INC: NDA SUBMISSION FOR ZIFTOMENIB ON TRACK FOR 2Q 2025

  • KURA ONCOLOGY INC: KOMET-017-IC AND NIC PHASE 3 TRIALS EXPECTED TO INITIATE IN 2H 2025

Source text: ID:nGNX4xK0s3

Further company coverage: 4151.T

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI